Tailored Assay Solutions AAV Immunogenicity and Safety Assessment
At Svar Life Science, we understand that no AAV vector is the same, and neither are your development needs. That’s why our AAV immunogenicity platform is built for flexibility, offering full vector specific customized assay solutions to support drug safety and efficacy in AAV-based gene therapy.
Our AAV safety trifecta solutions comprise of Neutralizing Antibody (NAb), Total Antibody (TAb), and Complement Activation (COMPL) assays that are all designed to provide a comprehensive view of vector immunogenicity. These assays are available as ready-to-use kits (for our Nab solution) or as customized on-demand products
Whether you need a single assay or a full immunogenicity and safety assessment package, we offer modular and scalable solutions to fit your project timeline and scope. Our business model is built around flexibility—each work order is independent and can be adapted to meet your specific requirements.
Explore our Assay Toolbox
Empower your research and drug development with precision and reliability.
When established assay isn’t enough, our customization services are here to meet you where you are. Whether you're working with a novel AAV vector, a specialized assay format, or navigating complex regulatory requirements, we offer flexible, expert-driven solutions tailored to your exact needs.
Our Customization Offering Includes:
Assay Development: Tailored to your unique vector, assay format, and intended application.
Assay Manufacturing: Production of your specific QC-tested plates or Assays Ready cells
With our deep expertise and agile infrastructure, we empower drug developers, researchers, sponsors, and regulatory teams with the tools they need to confidently assess AAV safety and immunogenicity - on your terms.
